pharmpro Sign Up Information

Aphena Pharma Solutions recently announced that it is spending $21 million to expand its Solid Dose Division in Cookeville, Tenn.

A federal judge in Virginia has sentenced opioid-addiction drug maker Indivior Solutions to pay $289 million in criminal penalties.

Boehringer Ingelheim has reached an agreement in principle to settle some 2,935 lawsuits tied to its blood thinner Pradaxa.

Bristol Myers Squibb posted third-quarter results that beat analysts’ consensus forecast while raising its outlook for the remainder of the year.

Royalty Pharma plc will acquire residual royalty interest in Vertex Pharmaceuticals’ cystic fibrosis (CF) treatments, which the Cystic Fibrosis Foundation owns.

Nostrum Laboratories is initiating the voluntary recall of two lots of its Metformin HCI extended-release tablets for people with diabetes.

Thermo Fisher Scientific Inc. and Innoforce have agreed to set up a new pharma services facility in Hangzhou, China for biologics and drug development and manufacturing. 

Medical supply firm McKesson announced in a quarterly report that it and two other drug distributors could pay as much as $21 billion in opioid lawsuit settlements over 18 years.

Thermo Fisher Scientific, the maker of scientific instruments, reagents and consumables, is having a banner year.

Palantir Technologies, the controversial data-mining company, will assist the U.S. government in tracking the administration of COVID-19 vaccines.

Some 48 people have died in South Korea after receiving flu shots, leading several physicians to call for a pause in immunizations.

Pfizer, a COVID-19 vaccine candidate frontrunner, inadvertently leaked data on patients taking drugs to treat cancer, nerve pain, erectile dysfunction, menopause and other conditions.

Professional thieves have long looted valuable medicines. Now, drugmakers and their partners are aiming to protect COVID-19 vaccines from theft.

Juganu, an Israeli startup, has developed a smart indoor light technology to fight against COVID-19.

FDA has granted emergency use authorization to the monoclonal antibody from Eli Lilly to improve the prognosis for recently diagnosed high-risk COVID-19 patients. 

CVS Health has committed to partnering with the Trump administration to administer Eli Lilly’s bamlanivimab.

Boston Scientific announced that it entered into a definitive agreement to sell its BTG Specialty Pharmaceuticals business.

The prospects of the pharmaceutical industry appear to be brightening, according to the credit-rating firm.

The majority of recipients of the COVID-19 vaccine from Moderna (NSDQ:MRNA) have had mild side effects such as headache, fatigue and pain at the injection site. Temporary facial swelling may be another side effect for vaccine recipients who have had prior dermal fillers.

NanoString Technologies Inc. has announced a spatial molecular imaging platform for multiplexed analysis of RNA and protein expression for individual cells within intact tissue samples.

The FDA has approved human clinical trials for Anixa Biosciences and Cleveland Clinic’s novel breast cancer vaccine that immunizes against the alpha-lactalbumin protein.

Artificial intelligence and data automation techniques could be a powerful tool combating one of the top hindrances to mass vaccination: vaccine hesitancy. 

Thermo Fisher Scientific has debuted a cryogenic transmission electron microscope that it claims “democratizes” the technique.

The FDA has approved an intentional genomic alteration (IGA) in a line of domestic pigs known as GalSafe, marking the first time the agency has signed off on a biotech product for both food applications and potential therapeutic use. 

An experimental drug appeared to restore normal memory and cognition function in mice, according to researchers at the University of California, San Francisco (UCSF). 

Researchers at Purdue University have devised chemical reactivity flowcharts and novel machine learning models that could accelerate drug discovery.